124 related articles for article (PubMed ID: 10874450)
21. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
22. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
Lodahl D; Schrøder H
Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
Santolaya ME; Cofre J; Beresi V
Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
[TBL] [Abstract][Full Text] [Related]
24. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
25. Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.
Bow EJ
Semin Hematol; 2009 Jul; 46(3):259-68. PubMed ID: 19549578
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
Abrahamsson J; Påhlman M; Mellander L
Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.
Vettenranta K; Hovi L; Mäkipernaa A; Jalanko H; Saarinen-Pihkala UM
Acta Paediatr; 2002; 91(8):915-9. PubMed ID: 12222715
[TBL] [Abstract][Full Text] [Related]
28. Fever and neutropenia in children with cancer: diagnostic parameters at presentation.
Riikonen P; Jalanko H; Hovi L; Saarinen UM
Acta Paediatr; 1993 Mar; 82(3):271-5. PubMed ID: 8495083
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology and diagnosis of cancer patients with febrile neutropenia].
Saito T; Aiba K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):684-7. PubMed ID: 23863643
[TBL] [Abstract][Full Text] [Related]
30. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Bilgir O; Bilgir F; Kebapcilar L; Bozkaya G; Çalan M; Kırbıyık H; Avci M; Sari İ; Yuksel A; Isikyakar T
Transfus Apher Sci; 2012 Feb; 46(1):19-24. PubMed ID: 22079264
[TBL] [Abstract][Full Text] [Related]
31. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
32. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
33. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
34. Serum cholesterol levels in neutropenic patients with fever.
Fraunberger P; Hahn J; Holler E; Walli AK; Seidel D
Clin Chem Lab Med; 2002 Mar; 40(3):304-7. PubMed ID: 12005222
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
Gac AC; Parienti JJ; Chantepie S; Fradin S; Le Coutour X; Leclercq R; Reman O
Leuk Res; 2011 Oct; 35(10):1294-6. PubMed ID: 21831426
[TBL] [Abstract][Full Text] [Related]
36. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer.
Katz JA; Mustafa MM; Bash RO; Cash JV; Buchanan GR
Pediatr Infect Dis J; 1992 Sep; 11(9):708-12. PubMed ID: 1448309
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.
Stryjewski GR; Nylen ES; Bell MJ; Snider RH; Becker KL; Wu A; Lawlor C; Dalton H
Pediatr Crit Care Med; 2005 Mar; 6(2):129-35. PubMed ID: 15730597
[TBL] [Abstract][Full Text] [Related]
38. Urinary albumin excretion and its relationship to C-reactive protein and proinflammatory cytokines in patients with cancer and febrile neutropenia.
Pedersen LM; Bergmann OJ
Scand J Infect Dis; 2003; 35(8):491-4. PubMed ID: 14514150
[TBL] [Abstract][Full Text] [Related]
39. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.
Phillips RS; Wade R; Lehrnbecher T; Stewart LA; Sutton AJ
BMC Med; 2012 Jan; 10():6. PubMed ID: 22257704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
